Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03157882 · ClinicalTrials.gov registry record

Pediatric Pain Assessment in the Emergency Department

A clinical trial, sponsored by Wake Forest University Health Sciences.

Terminated
Registry status
46
Enrollment target

NCT03157882: Clinical Trial study, sponsored by Wake Forest University Health Sciences.

NCT03157882 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03157882 was terminated before completion, sponsored by Wake Forest University Health Sciences.

TERMINATED
Registry status
46 participants
Enrollment target

Study Summary

To examine pediatric pain assessment in the Emergency Department

Primary Outcome

Adherence to a validated script for pain scale administration (dichotomous value - yes/no)

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2016-08-13
Est. Completion 2019-04-11
Wake Forest University Health Sciences

1,140 total trials

Why NCT03157882 stopped before completion

NCT03157882 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03157882 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03157882 about?

NCT03157882 is a clinical study titled "Pediatric Pain Assessment in the Emergency Department". To examine pediatric pain assessment in the Emergency Department

What is the current status of trial NCT03157882?

This trial is currently terminated. The enrollment target is 46 participants. The study started on 2016-08-13. Estimated completion is 2019-04-11.

Who is sponsoring clinical trial NCT03157882?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03157882, the US trial registry maintained by the National Library of Medicine. NCT03157882 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.